MEDIUM confidence: 100% data completeness, but the composite (48) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net insider -$7.4M over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $22.9B— | $28.1B+22.5% | $33.1B+18.0% | $36.3B+9.5% | $35.7B-1.6% |
| EPS (dil.) | $1.32— | $2.39+81.1% | $2.91+21.8% | $3.11+6.9% | $2.35-24.4% |
| Free Cash Flow | $3.5B— | $2.0B-42.2% | $4.5B+126.7% | $4.5B-1.6% | $4.5B+1.6% |
| Gross Margin | 16.0% | 18.4%+2.4pp | 19.8%+1.4pp | 20.6%+0.8pp | 18.2%-2.3pp |
| Operating Margin | 12.1% | 14.8%+2.7pp | 16.6%+1.8pp | 17.4%+0.8pp | 15.3%-2.2pp |
| Net Margin | 8.2% | 12.2%+4.0pp | 12.7%+0.4pp | 12.3%-0.4pp | 9.4%-2.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 6.5%/yr (revenue basis).
Base free cash flow $4.5B (avg FY2023–FY2025; latest year $4.5B) · equity value $79.3B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $68 (last qtr, 6 analysts) → $65 (last mo, 4) (-4.0%).
Buy-rated share 87% → 84% over ~3 months (-3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.62 | $0.64 | +3.7% |
| Jul 2026 | $0.51 | $0.55 | +7.6% |
| Apr 2026 | $0.51 | $0.52 | +2.4% |
| Jan 2026 | $0.74 | $0.78 | +5.1% |
| Oct 2025 | $0.66 | $0.69 | +5.0% |
| Jul 2025 | $0.72 | $0.74 | +2.5% |
| Apr 2025 | $0.73 | $0.72 | -1.9% |
| Jan 2025 | $0.90 | $0.92 | +2.2% |
The QScore of 48 for SLB indicates a neutral outlook, with the stock's short-term score exceeding its long-term score by 7 points. SLB scores high on momentum, driven by its +45.9% return over the past year, but is dragged down by lower scores in growth and profitability, reflecting its -24.2% EPS growth and modest ROE of 11.8%. The stock trades at a premium, with a P/E of 25.8, and exhibits strong momentum, but its risk profile is relatively stable, with a beta of 0.8.